Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase EARLY_PHASE1 4Phase NA 3Phase 1/2 2Phase 4 1Phase 2/3 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other 1

Conditions

Polycystic Ovary Syndrome 3Obesity 1Metabolic Syndrome 1Hyperandrogenism 1Cardiovascular Diseases 1

Interventions

Exercise 439Blood Specimen Collection 333Standard of Care 321Magnetic Resonance Spectroscopy 259Radiotherapy 255Surveys and Questionnaires 245Radiosurgery 245Educational Status 230Methods 229Early Intervention, Educational 218Practice Guidelines as Topic 146Interviews as Topic 146Biopsy 146Surgical Procedures, Operative 135Drug Therapy 133Control Groups 128Acupuncture Therapy 124Therapeutics 110Cyclophosphamide 103Palliative Care 101Counseling 101Resistance Training 95Saline Solution 90Cisplatin 90Magnetic Resonance Imaging 89Radiofrequency Ablation 86Specimen Handling 79Radiotherapy, Intensity-Modulated 79Colonoscopy 79Cognitive Behavioral Therapy 72

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Spironolactone × Clear all
NCT01422759 2023-10-27

Effect of Spironolactone on Adrenal or Ovarian Androgen Production in Overweight Pubertal Girls With Androgen Excess

University of Virginia

Phase NA Unknown
20 enrolled
Other

Obesity, Polycystic Ovary Syndrome

NCT01526616 2012-02-06

Spironolactone Plus Metformin in Polycystic Ovary Syndrome

University Magna Graecia

Phase NA Completed
56 enrolled

Polycystic Ovary Syndrome, Hyperandrogenism, Metabolic Syndrome

NCT00842140 2010-07-22

Safety of Hormonal Contraceptives Therapies in Polycystic Ovary Syndrome (PCOS) Women

University of Sao Paulo

Phase NA Completed
75 enrolled

Cardiovascular Diseases, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡